Keyphrases
Tumor Necrosis Factor-α
100%
Lipopolysaccharide-induced
100%
Acute Lung Injury
100%
Human MSCs
100%
Human multipotent Stromal Cells
100%
Lung
72%
Multipotent Stromal Cells
36%
TSG-6
36%
Lipopolysaccharide
27%
Microarray Analysis
18%
Inflammatory Cytokines
18%
Anti-inflammatory Effect
18%
Bronchoalveolar Lavage Fluid
18%
Total Protein
18%
Oropharyngeal Aspiration
18%
Lipopolysaccharide-induced Inflammation
18%
Knockdown
9%
Lung Injury
9%
Clinical Trials
9%
Beneficial Effects
9%
Rodents
9%
Inflammation
9%
RNA Interference
9%
Total RNA
9%
Recombinant Human
9%
Bone Marrow Cells
9%
Anti-inflammatory Properties
9%
Intraperitoneal Administration
9%
Rodent Models
9%
Neutrophil Count
9%
Bronchoalveolar Lavage
9%
Inflammatory Diseases
9%
Inflammatory Cells
9%
Cellular Expression
9%
Immunodeficient Mice
9%
Pulmonary Edema
9%
Lung Inflammation
9%
Cytokine Expression
9%
Pulmonary Delivery
9%
Weight Ratio
9%
Multiplex Immunoassay
9%
Wetting-drying
9%
TNFAIP6
9%
Medicine and Dentistry
Tumor Necrosis Factor
100%
Secretion (Process)
100%
Stromal Cell
100%
Lipopolysaccharide-Induced Acute Lung Injury
100%
Lung
100%
Acute Lung Injury
50%
Lipopolysaccharide
37%
Inflammatory Cytokine
25%
Bronchoalveolar Lavage Fluid
25%
Antiinflammatory Activity
25%
Microarray Analysis
25%
Protein
25%
Lipopolysaccharide-Induced Inflammation
25%
Neutrophil
12%
Clinical Trial
12%
Inflammatory Cell
12%
Anti-Inflammatory Drug
12%
Inflammatory Disorder
12%
Intraperitoneal Drug Administration
12%
Lung Lavage
12%
Pulmonary Edema
12%
Pneumonia
12%
Immunoassay
12%
RNAI
12%
Immunology and Microbiology
Secretion (Process)
100%
Tumor Necrosis Factor
100%
Bronchoalveolar Lavage Fluid
100%
Antiinflammatory Activity
100%
Cytokine
50%
Immunoassay
50%
Inflammatory Disorder
50%
Inflammatory Cell
50%
Proinflammatory Cytokine
50%
Neutrophil Count
50%
Pulmonary Inflammation
50%
Dry Weight
50%
RNAI
50%
Pharmacology, Toxicology and Pharmaceutical Science
Tumor Necrosis Factor
100%
Lipopolysaccharide-Induced Acute Lung Injury
100%
Acute Lung Injury
100%
Lipopolysaccharide
75%
Cytokine
50%
Antiinflammatory Activity
50%
Protein
50%
Lipopolysaccharide-Induced Inflammation
50%
Inflammation
25%
Clinical Trial
25%
Immunoassay
25%
Anti-Inflammatory Drug
25%
Inflammatory Disease
25%
Lung Edema
25%
Pneumonia
25%
Biochemistry, Genetics and Molecular Biology
Tumor Necrosis Factor
100%
Secretion (Process)
100%
Stromal Cell
100%
Lipopolysaccharide
100%
TSG-6
66%
Liquid
33%
Microarrays
33%
Antiinflammatory Activity
33%
Animal Model
16%
Clinical Trial
16%
Immunoassay
16%
Cytokine
16%
RNA
16%
Proinflammatory Cytokine
16%
Neutrophil Count
16%
Dry Weight
16%
RNAI
16%